Welcome to our dedicated page for Firsthand Technology Value Fund news (Ticker: SVVC), a resource for investors and traders seeking the latest updates and insights on Firsthand Technology Value Fund stock.
Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) is a publicly traded venture capital fund that invests in technology and cleantech companies, operating as a non-diversified, closed-end investment company that has elected to be treated as a business development company. The Fund regularly issues press releases detailing its financial results, portfolio valuation changes, and other significant developments, which form the core of the news flow associated with SVVC.
News about Firsthand Technology Value Fund frequently covers quarterly and annual financial results, including net asset value (NAV) per share, net assets, and the composition of its portfolio across equity and debt investments, cash and cash equivalents, and other assets. These updates often describe how the Valuation Committee, working with an independent valuation firm and following the Fund’s valuation procedures and ASC 820, has adjusted the fair values of private portfolio companies based on performance, recent transactions, and sector market multiples.
Investors following SVVC news can also see disclosures about fee waiver arrangements with its investment adviser, Firsthand Capital Management, Inc., and how these agreements affect reported management fees and net investment income or loss. In addition, the Fund has announced strategic reviews, such as the engagement of Ladenburg Thalmann & Co. Inc. to evaluate strategic options aimed at increasing stockholder value.
This news page aggregates such announcements, giving readers a centralized view of the Fund’s periodic financial reporting, valuation changes, portfolio developments, and Board-level decisions. For those tracking a venture capital-style fund focused on technology and cleantech companies, SVVC news provides insight into how its portfolio and capital structure evolve over time.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $14.33 as of September 30, 2021. The Fund's top holdings include IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and Hera Systems, which together represent 93.0% of its preliminary net assets. The total investments amount to $96.5 million, approximately $14.00 per share. The quarterly report, providing complete financial statements, will be available in November 2021, offering further insights into the Fund's performance and strategies.
Firsthand Technology Value Fund (NASDAQ: SVVC) revealed its top five holdings as of August 31, 2021. The top investments include IntraOp Medical (28.2%), Wrightspeed (25.2%), Pivotal Systems (21.9%), Revasum (14.2%), and Hera Systems (5.2%), together constituting 94.6% of the Fund’s estimated total investments of approximately $107.7 million, or $15.63 per share. The complete financial details will be available in the upcoming quarterly report in November 2021. The Fund focuses on long-term growth through investments in technology and cleantech companies.
Firsthand Technology Value Fund (NASDAQ: SVVC) has disclosed its top five holdings as of July 31, 2021, which represent 93.3% of its estimated total investments of approximately $107.1 million, or $15.54 per share. The holdings include:
- IntraOp Medical - 28.3% of total investments.
- Wrightspeed - 24.4% of total investments.
- Pivotal Systems - 22.6% of total investments.
- Revasum - 12.8% of total investments.
- Hera Systems - 5.1% of total investments.
More detailed financial statements will be available in the quarterly report in November 2021.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its Q2 2021 financial results, showing net assets of approximately $107.3 million, or $15.57 per share, down from $112.4 million, or $16.31 per share in Q1. The Fund's portfolio includes public and private securities valued at about $102.5 million. Investment income for the quarter was approximately $1.4 million with net investment income of around $554 thousand. However, the Fund experienced net realized and unrealized losses of approximately $5.6 million. The management continues to strategize for portfolio enhancement.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $15.57 per share as of June 30, 2021. The fund's top five investments include IntraOp Medical, Pivotal Systems, Wrightspeed, Revasum, and Hera Systems, comprising 90.5% of the fund's preliminary net assets. The total investment is reported at $102.5 million, equating to approximately $14.87 per share. Cash and cash equivalents are approximately $0.50 per share. Detailed financial statements will be released with the upcoming quarterly report.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its top five holdings as of May 31, 2021, which represent 87.4% of the Fund's estimated total investments of approximately $112 million. The leading investment is in IntraOp Medical, accounting for about 26.7% of total investments, followed by Wrightspeed at 25.7%, Pivotal Systems at 21.5%, Revasum at 9.9%, and Hera Systems at 3.6%. The estimated value per share stands at $16.21, with cash and equivalents at approximately $0.77 per share. A detailed financial report will be available in August 2021.
Firsthand Technology Value Fund (SVVC) announced its Q1 2021 results, reporting net assets of approximately $112.4 million, or $16.31 per share, compared to $102.1 million at year-end 2020. The portfolio consisted of investments valued at $111.2 million and cash equivalents of $0.5 million. The Fund generated investment income of approximately $1.3 million and net investment income of around $508 thousand. Notably, the Fund recorded net gains of $9.8 million on investments.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced a preliminary NAV of $16.31 as of March 31, 2021. The Fund's top five holdings include Pivotal Systems (27.3%), IntraOp Medical (25.7%), Wrightspeed (23.6%), Revasum (11.2%), and Hera Systems (3.3%), collectively comprising 91.1% of its net assets. Total investments reached $111.2 million or approximately $16.14 per share. Cash equivalents stand at $0.07 per share. A full report will be available in May 2021.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its fiscal results for 2020, showing a significant decline in net assets from $127.1 million ($17.70 per share) in 2019 to $102.1 million ($14.82 per share) in 2020. The investment income was approximately $3.7 million, while the fund reported net realized and unrealized losses of about $23.6 million. The portfolio included $99.7 million in equity/debt investments and $2.37 million in cash equivalents. The Valuation Committee adjusted the fair values of private companies considering performance and market changes.
As of February 28, 2021, Firsthand Technology Value Fund (NASDAQ: SVVC) disclosed its top five holdings comprising IntraOp Medical, Pivotal Systems, Wrightspeed, Revasum, and SVXR, which together accounted for 90.7% of the Fund's estimated total investments of approximately $109 million, or $15.77 per share. IntraOp Medical represents the largest stake at about 24.3%, followed closely by Pivotal Systems at 23.6%, and Wrightspeed at 23.0%. A comprehensive financial report will be available in May 2021.